Study ID: XM02-ONC-201 | 2014-001772-55
Study Title
- A Study to Evaluate 5 ־¼g/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement
Teva Identifier
- XM02-ONC-201 | 2014-001772-55
ClinicalTrials.gov Identifier
- NCT02190721
Study Status
- Completed
Trial Condition(s)
- Neutropenia
Interventions
- Drug: tbo-filgrastim
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 1 Month to 16 Years
Trial Duration
- May 12, 2015 - April 4, 2017
Phase
- Phase 2
Study Type
Interventional